Global Synthetic Blood Substitutes Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Synthetic Blood Substitutes Industry Forecast” looks at past sales and reviews total world Synthetic Blood Substitutes sales in 2022, providing a comprehensive analysis by region and market sector of projected Synthetic Blood Substitutes sales for 2023 through 2029. With Synthetic Blood Substitutes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Blood Substitutes industry.
This Insight Report provides a comprehensive analysis of the global Synthetic Blood Substitutes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Blood Substitutes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Synthetic Blood Substitutes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Blood Substitutes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Blood Substitutes.
The global Synthetic Blood Substitutes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Synthetic Blood Substitutes players cover Hemarina, Sagart Corporation, FLUORO2 Therapeutics, Biopure Corporation, Alpha Therapeutic Corporation, KaloCyte, Baxter, Green Cross Corporation and North Field Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Blood Substitutes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Synthetic Blood Substitutes market?
What factors are driving Synthetic Blood Substitutes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Synthetic Blood Substitutes market opportunities vary by end market size?
How does Synthetic Blood Substitutes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Synthetic Blood Substitutes Industry Forecast” looks at past sales and reviews total world Synthetic Blood Substitutes sales in 2022, providing a comprehensive analysis by region and market sector of projected Synthetic Blood Substitutes sales for 2023 through 2029. With Synthetic Blood Substitutes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Blood Substitutes industry.
This Insight Report provides a comprehensive analysis of the global Synthetic Blood Substitutes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Blood Substitutes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Synthetic Blood Substitutes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Blood Substitutes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Blood Substitutes.
The global Synthetic Blood Substitutes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Synthetic Blood Substitutes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Synthetic Blood Substitutes players cover Hemarina, Sagart Corporation, FLUORO2 Therapeutics, Biopure Corporation, Alpha Therapeutic Corporation, KaloCyte, Baxter, Green Cross Corporation and North Field Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Blood Substitutes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- by Product Type
- Hemoglobin-Based Oxygen Carriers (HBOCs)
- Perfluorocarbon (PFCs)
- Others
- by Source
- Human Blood
- Animal Blood
- Microorganisms
- Synthetic Polymers
- Stem Cells
- Others
- Cardiovascular Diseases
- Anemia
- Malignant Neoplasm
- Injuries and Trauma
- Neonatal Conditions
- Maternal Conditions
- Organ Transplant
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hemarina
- Sagart Corporation
- FLUORO2 Therapeutics
- Biopure Corporation
- Alpha Therapeutic Corporation
- KaloCyte
- Baxter
- Green Cross Corporation
- North Field Laboratories
- Alliance Pharmaceutical Corporation
What is the 10-year outlook for the global Synthetic Blood Substitutes market?
What factors are driving Synthetic Blood Substitutes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Synthetic Blood Substitutes market opportunities vary by end market size?
How does Synthetic Blood Substitutes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Synthetic Blood Substitutes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Synthetic Blood Substitutes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Synthetic Blood Substitutes by Country/Region, 2018, 2022 & 2029
2.2 Synthetic Blood Substitutes Segment by Type
2.2.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
2.2.2 Perfluorocarbon (PFCs)
2.2.3 Others
2.3 Synthetic Blood Substitutes Sales by Type
2.3.1 Global Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
2.3.2 Global Synthetic Blood Substitutes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Synthetic Blood Substitutes Sale Price by Type (2018-2023)
2.4 Synthetic Blood Substitutes Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Malignant Neoplasm
2.4.4 Injuries and Trauma
2.4.5 Neonatal Conditions
2.4.6 Maternal Conditions
2.4.7 Organ Transplant
2.4.8 Others
2.5 Synthetic Blood Substitutes Sales by Application
2.5.1 Global Synthetic Blood Substitutes Sale Market Share by Application (2018-2023)
2.5.2 Global Synthetic Blood Substitutes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Synthetic Blood Substitutes Sale Price by Application (2018-2023)
3 GLOBAL SYNTHETIC BLOOD SUBSTITUTES BY COMPANY
3.1 Global Synthetic Blood Substitutes Breakdown Data by Company
3.1.1 Global Synthetic Blood Substitutes Annual Sales by Company (2018-2023)
3.1.2 Global Synthetic Blood Substitutes Sales Market Share by Company (2018-2023)
3.2 Global Synthetic Blood Substitutes Annual Revenue by Company (2018-2023)
3.2.1 Global Synthetic Blood Substitutes Revenue by Company (2018-2023)
3.2.2 Global Synthetic Blood Substitutes Revenue Market Share by Company (2018-2023)
3.3 Global Synthetic Blood Substitutes Sale Price by Company
3.4 Key Manufacturers Synthetic Blood Substitutes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Synthetic Blood Substitutes Product Location Distribution
3.4.2 Players Synthetic Blood Substitutes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SYNTHETIC BLOOD SUBSTITUTES BY GEOGRAPHIC REGION
4.1 World Historic Synthetic Blood Substitutes Market Size by Geographic Region (2018-2023)
4.1.1 Global Synthetic Blood Substitutes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Synthetic Blood Substitutes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Synthetic Blood Substitutes Market Size by Country/Region (2018-2023)
4.2.1 Global Synthetic Blood Substitutes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Synthetic Blood Substitutes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Synthetic Blood Substitutes Sales Growth
4.4 APAC Synthetic Blood Substitutes Sales Growth
4.5 Europe Synthetic Blood Substitutes Sales Growth
4.6 Middle East & Africa Synthetic Blood Substitutes Sales Growth
5 AMERICAS
5.1 Americas Synthetic Blood Substitutes Sales by Country
5.1.1 Americas Synthetic Blood Substitutes Sales by Country (2018-2023)
5.1.2 Americas Synthetic Blood Substitutes Revenue by Country (2018-2023)
5.2 Americas Synthetic Blood Substitutes Sales by Type
5.3 Americas Synthetic Blood Substitutes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Synthetic Blood Substitutes Sales by Region
6.1.1 APAC Synthetic Blood Substitutes Sales by Region (2018-2023)
6.1.2 APAC Synthetic Blood Substitutes Revenue by Region (2018-2023)
6.2 APAC Synthetic Blood Substitutes Sales by Type
6.3 APAC Synthetic Blood Substitutes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Synthetic Blood Substitutes by Country
7.1.1 Europe Synthetic Blood Substitutes Sales by Country (2018-2023)
7.1.2 Europe Synthetic Blood Substitutes Revenue by Country (2018-2023)
7.2 Europe Synthetic Blood Substitutes Sales by Type
7.3 Europe Synthetic Blood Substitutes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Synthetic Blood Substitutes by Country
8.1.1 Middle East & Africa Synthetic Blood Substitutes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2018-2023)
8.2 Middle East & Africa Synthetic Blood Substitutes Sales by Type
8.3 Middle East & Africa Synthetic Blood Substitutes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Synthetic Blood Substitutes
10.3 Manufacturing Process Analysis of Synthetic Blood Substitutes
10.4 Industry Chain Structure of Synthetic Blood Substitutes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Synthetic Blood Substitutes Distributors
11.3 Synthetic Blood Substitutes Customer
12 WORLD FORECAST REVIEW FOR SYNTHETIC BLOOD SUBSTITUTES BY GEOGRAPHIC REGION
12.1 Global Synthetic Blood Substitutes Market Size Forecast by Region
12.1.1 Global Synthetic Blood Substitutes Forecast by Region (2024-2029)
12.1.2 Global Synthetic Blood Substitutes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Synthetic Blood Substitutes Forecast by Type
12.7 Global Synthetic Blood Substitutes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hemarina
13.1.1 Hemarina Company Information
13.1.2 Hemarina Synthetic Blood Substitutes Product Portfolios and Specifications
13.1.3 Hemarina Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hemarina Main Business Overview
13.1.5 Hemarina Latest Developments
13.2 Sagart Corporation
13.2.1 Sagart Corporation Company Information
13.2.2 Sagart Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.2.3 Sagart Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sagart Corporation Main Business Overview
13.2.5 Sagart Corporation Latest Developments
13.3 FLUORO2 Therapeutics
13.3.1 FLUORO2 Therapeutics Company Information
13.3.2 FLUORO2 Therapeutics Synthetic Blood Substitutes Product Portfolios and Specifications
13.3.3 FLUORO2 Therapeutics Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 FLUORO2 Therapeutics Main Business Overview
13.3.5 FLUORO2 Therapeutics Latest Developments
13.4 Biopure Corporation
13.4.1 Biopure Corporation Company Information
13.4.2 Biopure Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.4.3 Biopure Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Biopure Corporation Main Business Overview
13.4.5 Biopure Corporation Latest Developments
13.5 Alpha Therapeutic Corporation
13.5.1 Alpha Therapeutic Corporation Company Information
13.5.2 Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.5.3 Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alpha Therapeutic Corporation Main Business Overview
13.5.5 Alpha Therapeutic Corporation Latest Developments
13.6 KaloCyte
13.6.1 KaloCyte Company Information
13.6.2 KaloCyte Synthetic Blood Substitutes Product Portfolios and Specifications
13.6.3 KaloCyte Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 KaloCyte Main Business Overview
13.6.5 KaloCyte Latest Developments
13.7 Baxter
13.7.1 Baxter Company Information
13.7.2 Baxter Synthetic Blood Substitutes Product Portfolios and Specifications
13.7.3 Baxter Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Baxter Main Business Overview
13.7.5 Baxter Latest Developments
13.8 Green Cross Corporation
13.8.1 Green Cross Corporation Company Information
13.8.2 Green Cross Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.8.3 Green Cross Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Green Cross Corporation Main Business Overview
13.8.5 Green Cross Corporation Latest Developments
13.9 North Field Laboratories
13.9.1 North Field Laboratories Company Information
13.9.2 North Field Laboratories Synthetic Blood Substitutes Product Portfolios and Specifications
13.9.3 North Field Laboratories Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 North Field Laboratories Main Business Overview
13.9.5 North Field Laboratories Latest Developments
13.10 Alliance Pharmaceutical Corporation
13.10.1 Alliance Pharmaceutical Corporation Company Information
13.10.2 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.10.3 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Alliance Pharmaceutical Corporation Main Business Overview
13.10.5 Alliance Pharmaceutical Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Synthetic Blood Substitutes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Synthetic Blood Substitutes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Synthetic Blood Substitutes by Country/Region, 2018, 2022 & 2029
2.2 Synthetic Blood Substitutes Segment by Type
2.2.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
2.2.2 Perfluorocarbon (PFCs)
2.2.3 Others
2.3 Synthetic Blood Substitutes Sales by Type
2.3.1 Global Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
2.3.2 Global Synthetic Blood Substitutes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Synthetic Blood Substitutes Sale Price by Type (2018-2023)
2.4 Synthetic Blood Substitutes Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Malignant Neoplasm
2.4.4 Injuries and Trauma
2.4.5 Neonatal Conditions
2.4.6 Maternal Conditions
2.4.7 Organ Transplant
2.4.8 Others
2.5 Synthetic Blood Substitutes Sales by Application
2.5.1 Global Synthetic Blood Substitutes Sale Market Share by Application (2018-2023)
2.5.2 Global Synthetic Blood Substitutes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Synthetic Blood Substitutes Sale Price by Application (2018-2023)
3 GLOBAL SYNTHETIC BLOOD SUBSTITUTES BY COMPANY
3.1 Global Synthetic Blood Substitutes Breakdown Data by Company
3.1.1 Global Synthetic Blood Substitutes Annual Sales by Company (2018-2023)
3.1.2 Global Synthetic Blood Substitutes Sales Market Share by Company (2018-2023)
3.2 Global Synthetic Blood Substitutes Annual Revenue by Company (2018-2023)
3.2.1 Global Synthetic Blood Substitutes Revenue by Company (2018-2023)
3.2.2 Global Synthetic Blood Substitutes Revenue Market Share by Company (2018-2023)
3.3 Global Synthetic Blood Substitutes Sale Price by Company
3.4 Key Manufacturers Synthetic Blood Substitutes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Synthetic Blood Substitutes Product Location Distribution
3.4.2 Players Synthetic Blood Substitutes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SYNTHETIC BLOOD SUBSTITUTES BY GEOGRAPHIC REGION
4.1 World Historic Synthetic Blood Substitutes Market Size by Geographic Region (2018-2023)
4.1.1 Global Synthetic Blood Substitutes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Synthetic Blood Substitutes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Synthetic Blood Substitutes Market Size by Country/Region (2018-2023)
4.2.1 Global Synthetic Blood Substitutes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Synthetic Blood Substitutes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Synthetic Blood Substitutes Sales Growth
4.4 APAC Synthetic Blood Substitutes Sales Growth
4.5 Europe Synthetic Blood Substitutes Sales Growth
4.6 Middle East & Africa Synthetic Blood Substitutes Sales Growth
5 AMERICAS
5.1 Americas Synthetic Blood Substitutes Sales by Country
5.1.1 Americas Synthetic Blood Substitutes Sales by Country (2018-2023)
5.1.2 Americas Synthetic Blood Substitutes Revenue by Country (2018-2023)
5.2 Americas Synthetic Blood Substitutes Sales by Type
5.3 Americas Synthetic Blood Substitutes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Synthetic Blood Substitutes Sales by Region
6.1.1 APAC Synthetic Blood Substitutes Sales by Region (2018-2023)
6.1.2 APAC Synthetic Blood Substitutes Revenue by Region (2018-2023)
6.2 APAC Synthetic Blood Substitutes Sales by Type
6.3 APAC Synthetic Blood Substitutes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Synthetic Blood Substitutes by Country
7.1.1 Europe Synthetic Blood Substitutes Sales by Country (2018-2023)
7.1.2 Europe Synthetic Blood Substitutes Revenue by Country (2018-2023)
7.2 Europe Synthetic Blood Substitutes Sales by Type
7.3 Europe Synthetic Blood Substitutes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Synthetic Blood Substitutes by Country
8.1.1 Middle East & Africa Synthetic Blood Substitutes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2018-2023)
8.2 Middle East & Africa Synthetic Blood Substitutes Sales by Type
8.3 Middle East & Africa Synthetic Blood Substitutes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Synthetic Blood Substitutes
10.3 Manufacturing Process Analysis of Synthetic Blood Substitutes
10.4 Industry Chain Structure of Synthetic Blood Substitutes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Synthetic Blood Substitutes Distributors
11.3 Synthetic Blood Substitutes Customer
12 WORLD FORECAST REVIEW FOR SYNTHETIC BLOOD SUBSTITUTES BY GEOGRAPHIC REGION
12.1 Global Synthetic Blood Substitutes Market Size Forecast by Region
12.1.1 Global Synthetic Blood Substitutes Forecast by Region (2024-2029)
12.1.2 Global Synthetic Blood Substitutes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Synthetic Blood Substitutes Forecast by Type
12.7 Global Synthetic Blood Substitutes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hemarina
13.1.1 Hemarina Company Information
13.1.2 Hemarina Synthetic Blood Substitutes Product Portfolios and Specifications
13.1.3 Hemarina Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hemarina Main Business Overview
13.1.5 Hemarina Latest Developments
13.2 Sagart Corporation
13.2.1 Sagart Corporation Company Information
13.2.2 Sagart Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.2.3 Sagart Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sagart Corporation Main Business Overview
13.2.5 Sagart Corporation Latest Developments
13.3 FLUORO2 Therapeutics
13.3.1 FLUORO2 Therapeutics Company Information
13.3.2 FLUORO2 Therapeutics Synthetic Blood Substitutes Product Portfolios and Specifications
13.3.3 FLUORO2 Therapeutics Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 FLUORO2 Therapeutics Main Business Overview
13.3.5 FLUORO2 Therapeutics Latest Developments
13.4 Biopure Corporation
13.4.1 Biopure Corporation Company Information
13.4.2 Biopure Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.4.3 Biopure Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Biopure Corporation Main Business Overview
13.4.5 Biopure Corporation Latest Developments
13.5 Alpha Therapeutic Corporation
13.5.1 Alpha Therapeutic Corporation Company Information
13.5.2 Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.5.3 Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alpha Therapeutic Corporation Main Business Overview
13.5.5 Alpha Therapeutic Corporation Latest Developments
13.6 KaloCyte
13.6.1 KaloCyte Company Information
13.6.2 KaloCyte Synthetic Blood Substitutes Product Portfolios and Specifications
13.6.3 KaloCyte Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 KaloCyte Main Business Overview
13.6.5 KaloCyte Latest Developments
13.7 Baxter
13.7.1 Baxter Company Information
13.7.2 Baxter Synthetic Blood Substitutes Product Portfolios and Specifications
13.7.3 Baxter Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Baxter Main Business Overview
13.7.5 Baxter Latest Developments
13.8 Green Cross Corporation
13.8.1 Green Cross Corporation Company Information
13.8.2 Green Cross Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.8.3 Green Cross Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Green Cross Corporation Main Business Overview
13.8.5 Green Cross Corporation Latest Developments
13.9 North Field Laboratories
13.9.1 North Field Laboratories Company Information
13.9.2 North Field Laboratories Synthetic Blood Substitutes Product Portfolios and Specifications
13.9.3 North Field Laboratories Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 North Field Laboratories Main Business Overview
13.9.5 North Field Laboratories Latest Developments
13.10 Alliance Pharmaceutical Corporation
13.10.1 Alliance Pharmaceutical Corporation Company Information
13.10.2 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
13.10.3 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Alliance Pharmaceutical Corporation Main Business Overview
13.10.5 Alliance Pharmaceutical Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Synthetic Blood Substitutes Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Synthetic Blood Substitutes Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemoglobin-Based Oxygen Carriers (HBOCs)
Table 4. Major Players of Perfluorocarbon (PFCs)
Table 5. Major Players of Others
Table 6. Global Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 7. Global Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Table 8. Global Synthetic Blood Substitutes Revenue by Type (2018-2023) & ($ million)
Table 9. Global Synthetic Blood Substitutes Revenue Market Share by Type (2018-2023)
Table 10. Global Synthetic Blood Substitutes Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 12. Global Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Table 13. Global Synthetic Blood Substitutes Revenue by Application (2018-2023)
Table 14. Global Synthetic Blood Substitutes Revenue Market Share by Application (2018-2023)
Table 15. Global Synthetic Blood Substitutes Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Synthetic Blood Substitutes Sales by Company (2018-2023) & (Kiloton)
Table 17. Global Synthetic Blood Substitutes Sales Market Share by Company (2018-2023)
Table 18. Global Synthetic Blood Substitutes Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Synthetic Blood Substitutes Revenue Market Share by Company (2018-2023)
Table 20. Global Synthetic Blood Substitutes Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Synthetic Blood Substitutes Producing Area Distribution and Sales Area
Table 22. Players Synthetic Blood Substitutes Products Offered
Table 23. Synthetic Blood Substitutes Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Synthetic Blood Substitutes Sales by Geographic Region (2018-2023) & (Kiloton)
Table 27. Global Synthetic Blood Substitutes Sales Market Share Geographic Region (2018-2023)
Table 28. Global Synthetic Blood Substitutes Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Synthetic Blood Substitutes Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Synthetic Blood Substitutes Sales by Country/Region (2018-2023) & (Kiloton)
Table 31. Global Synthetic Blood Substitutes Sales Market Share by Country/Region (2018-2023)
Table 32. Global Synthetic Blood Substitutes Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Synthetic Blood Substitutes Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 35. Americas Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 36. Americas Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 38. Americas Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 39. Americas Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 40. APAC Synthetic Blood Substitutes Sales by Region (2018-2023) & (Kiloton)
Table 41. APAC Synthetic Blood Substitutes Sales Market Share by Region (2018-2023)
Table 42. APAC Synthetic Blood Substitutes Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Synthetic Blood Substitutes Revenue Market Share by Region (2018-2023)
Table 44. APAC Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 45. APAC Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 46. Europe Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 47. Europe Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 48. Europe Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 50. Europe Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 51. Europe Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Synthetic Blood Substitutes
Table 59. Key Market Challenges & Risks of Synthetic Blood Substitutes
Table 60. Key Industry Trends of Synthetic Blood Substitutes
Table 61. Synthetic Blood Substitutes Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Synthetic Blood Substitutes Distributors List
Table 64. Synthetic Blood Substitutes Customer List
Table 65. Global Synthetic Blood Substitutes Sales Forecast by Region (2024-2029) & (Kiloton)
Table 66. Global Synthetic Blood Substitutes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 68. Americas Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Synthetic Blood Substitutes Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. APAC Synthetic Blood Substitutes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Europe Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Middle East & Africa Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Synthetic Blood Substitutes Sales Forecast by Type (2024-2029) & (Kiloton)
Table 76. Global Synthetic Blood Substitutes Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Synthetic Blood Substitutes Sales Forecast by Application (2024-2029) & (Kiloton)
Table 78. Global Synthetic Blood Substitutes Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Hemarina Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 80. Hemarina Synthetic Blood Substitutes Product Portfolios and Specifications
Table 81. Hemarina Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. Hemarina Main Business
Table 83. Hemarina Latest Developments
Table 84. Sagart Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 85. Sagart Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 86. Sagart Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Sagart Corporation Main Business
Table 88. Sagart Corporation Latest Developments
Table 89. FLUORO2 Therapeutics Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 90. FLUORO2 Therapeutics Synthetic Blood Substitutes Product Portfolios and Specifications
Table 91. FLUORO2 Therapeutics Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. FLUORO2 Therapeutics Main Business
Table 93. FLUORO2 Therapeutics Latest Developments
Table 94. Biopure Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 95. Biopure Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 96. Biopure Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Biopure Corporation Main Business
Table 98. Biopure Corporation Latest Developments
Table 99. Alpha Therapeutic Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 100. Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 101. Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Alpha Therapeutic Corporation Main Business
Table 103. Alpha Therapeutic Corporation Latest Developments
Table 104. KaloCyte Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 105. KaloCyte Synthetic Blood Substitutes Product Portfolios and Specifications
Table 106. KaloCyte Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. KaloCyte Main Business
Table 108. KaloCyte Latest Developments
Table 109. Baxter Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 110. Baxter Synthetic Blood Substitutes Product Portfolios and Specifications
Table 111. Baxter Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Baxter Main Business
Table 113. Baxter Latest Developments
Table 114. Green Cross Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 115. Green Cross Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 116. Green Cross Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Green Cross Corporation Main Business
Table 118. Green Cross Corporation Latest Developments
Table 119. North Field Laboratories Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 120. North Field Laboratories Synthetic Blood Substitutes Product Portfolios and Specifications
Table 121. North Field Laboratories Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. North Field Laboratories Main Business
Table 123. North Field Laboratories Latest Developments
Table 124. Alliance Pharmaceutical Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 125. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 126. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Alliance Pharmaceutical Corporation Main Business
Table 128. Alliance Pharmaceutical Corporation Latest Developments
Table 1. Synthetic Blood Substitutes Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Synthetic Blood Substitutes Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemoglobin-Based Oxygen Carriers (HBOCs)
Table 4. Major Players of Perfluorocarbon (PFCs)
Table 5. Major Players of Others
Table 6. Global Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 7. Global Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Table 8. Global Synthetic Blood Substitutes Revenue by Type (2018-2023) & ($ million)
Table 9. Global Synthetic Blood Substitutes Revenue Market Share by Type (2018-2023)
Table 10. Global Synthetic Blood Substitutes Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 12. Global Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Table 13. Global Synthetic Blood Substitutes Revenue by Application (2018-2023)
Table 14. Global Synthetic Blood Substitutes Revenue Market Share by Application (2018-2023)
Table 15. Global Synthetic Blood Substitutes Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Synthetic Blood Substitutes Sales by Company (2018-2023) & (Kiloton)
Table 17. Global Synthetic Blood Substitutes Sales Market Share by Company (2018-2023)
Table 18. Global Synthetic Blood Substitutes Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Synthetic Blood Substitutes Revenue Market Share by Company (2018-2023)
Table 20. Global Synthetic Blood Substitutes Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Synthetic Blood Substitutes Producing Area Distribution and Sales Area
Table 22. Players Synthetic Blood Substitutes Products Offered
Table 23. Synthetic Blood Substitutes Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Synthetic Blood Substitutes Sales by Geographic Region (2018-2023) & (Kiloton)
Table 27. Global Synthetic Blood Substitutes Sales Market Share Geographic Region (2018-2023)
Table 28. Global Synthetic Blood Substitutes Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Synthetic Blood Substitutes Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Synthetic Blood Substitutes Sales by Country/Region (2018-2023) & (Kiloton)
Table 31. Global Synthetic Blood Substitutes Sales Market Share by Country/Region (2018-2023)
Table 32. Global Synthetic Blood Substitutes Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Synthetic Blood Substitutes Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 35. Americas Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 36. Americas Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 38. Americas Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 39. Americas Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 40. APAC Synthetic Blood Substitutes Sales by Region (2018-2023) & (Kiloton)
Table 41. APAC Synthetic Blood Substitutes Sales Market Share by Region (2018-2023)
Table 42. APAC Synthetic Blood Substitutes Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Synthetic Blood Substitutes Revenue Market Share by Region (2018-2023)
Table 44. APAC Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 45. APAC Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 46. Europe Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 47. Europe Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 48. Europe Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 50. Europe Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 51. Europe Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Synthetic Blood Substitutes Sales by Country (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Synthetic Blood Substitutes Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Synthetic Blood Substitutes Sales by Type (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Synthetic Blood Substitutes Sales by Application (2018-2023) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Synthetic Blood Substitutes
Table 59. Key Market Challenges & Risks of Synthetic Blood Substitutes
Table 60. Key Industry Trends of Synthetic Blood Substitutes
Table 61. Synthetic Blood Substitutes Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Synthetic Blood Substitutes Distributors List
Table 64. Synthetic Blood Substitutes Customer List
Table 65. Global Synthetic Blood Substitutes Sales Forecast by Region (2024-2029) & (Kiloton)
Table 66. Global Synthetic Blood Substitutes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 68. Americas Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Synthetic Blood Substitutes Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. APAC Synthetic Blood Substitutes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Europe Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Synthetic Blood Substitutes Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Middle East & Africa Synthetic Blood Substitutes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Synthetic Blood Substitutes Sales Forecast by Type (2024-2029) & (Kiloton)
Table 76. Global Synthetic Blood Substitutes Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Synthetic Blood Substitutes Sales Forecast by Application (2024-2029) & (Kiloton)
Table 78. Global Synthetic Blood Substitutes Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Hemarina Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 80. Hemarina Synthetic Blood Substitutes Product Portfolios and Specifications
Table 81. Hemarina Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. Hemarina Main Business
Table 83. Hemarina Latest Developments
Table 84. Sagart Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 85. Sagart Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 86. Sagart Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Sagart Corporation Main Business
Table 88. Sagart Corporation Latest Developments
Table 89. FLUORO2 Therapeutics Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 90. FLUORO2 Therapeutics Synthetic Blood Substitutes Product Portfolios and Specifications
Table 91. FLUORO2 Therapeutics Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. FLUORO2 Therapeutics Main Business
Table 93. FLUORO2 Therapeutics Latest Developments
Table 94. Biopure Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 95. Biopure Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 96. Biopure Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Biopure Corporation Main Business
Table 98. Biopure Corporation Latest Developments
Table 99. Alpha Therapeutic Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 100. Alpha Therapeutic Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 101. Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Alpha Therapeutic Corporation Main Business
Table 103. Alpha Therapeutic Corporation Latest Developments
Table 104. KaloCyte Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 105. KaloCyte Synthetic Blood Substitutes Product Portfolios and Specifications
Table 106. KaloCyte Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. KaloCyte Main Business
Table 108. KaloCyte Latest Developments
Table 109. Baxter Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 110. Baxter Synthetic Blood Substitutes Product Portfolios and Specifications
Table 111. Baxter Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Baxter Main Business
Table 113. Baxter Latest Developments
Table 114. Green Cross Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 115. Green Cross Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 116. Green Cross Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Green Cross Corporation Main Business
Table 118. Green Cross Corporation Latest Developments
Table 119. North Field Laboratories Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 120. North Field Laboratories Synthetic Blood Substitutes Product Portfolios and Specifications
Table 121. North Field Laboratories Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. North Field Laboratories Main Business
Table 123. North Field Laboratories Latest Developments
Table 124. Alliance Pharmaceutical Corporation Basic Information, Synthetic Blood Substitutes Manufacturing Base, Sales Area and Its Competitors
Table 125. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Product Portfolios and Specifications
Table 126. Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Alliance Pharmaceutical Corporation Main Business
Table 128. Alliance Pharmaceutical Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Synthetic Blood Substitutes
Figure 2. Synthetic Blood Substitutes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Synthetic Blood Substitutes Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Synthetic Blood Substitutes Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Synthetic Blood Substitutes Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemoglobin-Based Oxygen Carriers (HBOCs)
Figure 10. Product Picture of Perfluorocarbon (PFCs)
Figure 11. Product Picture of Others
Figure 12. Global Synthetic Blood Substitutes Sales Market Share by Type in 2022
Figure 13. Global Synthetic Blood Substitutes Revenue Market Share by Type (2018-2023)
Figure 14. Synthetic Blood Substitutes Consumed in Cardiovascular Diseases
Figure 15. Global Synthetic Blood Substitutes Market: Cardiovascular Diseases (2018-2023) & (Kiloton)
Figure 16. Synthetic Blood Substitutes Consumed in Anemia
Figure 17. Global Synthetic Blood Substitutes Market: Anemia (2018-2023) & (Kiloton)
Figure 18. Synthetic Blood Substitutes Consumed in Malignant Neoplasm
Figure 19. Global Synthetic Blood Substitutes Market: Malignant Neoplasm (2018-2023) & (Kiloton)
Figure 20. Synthetic Blood Substitutes Consumed in Injuries and Trauma
Figure 21. Global Synthetic Blood Substitutes Market: Injuries and Trauma (2018-2023) & (Kiloton)
Figure 22. Synthetic Blood Substitutes Consumed in Neonatal Conditions
Figure 23. Global Synthetic Blood Substitutes Market: Neonatal Conditions (2018-2023) & (Kiloton)
Figure 24. Synthetic Blood Substitutes Consumed in Maternal Conditions
Figure 25. Global Synthetic Blood Substitutes Market: Maternal Conditions (2018-2023) & (Kiloton)
Figure 26. Synthetic Blood Substitutes Consumed in Organ Transplant
Figure 27. Global Synthetic Blood Substitutes Market: Organ Transplant (2018-2023) & (Kiloton)
Figure 28. Synthetic Blood Substitutes Consumed in Others
Figure 29. Global Synthetic Blood Substitutes Market: Others (2018-2023) & (Kiloton)
Figure 30. Global Synthetic Blood Substitutes Sales Market Share by Application (2022)
Figure 31. Global Synthetic Blood Substitutes Revenue Market Share by Application in 2022
Figure 32. Synthetic Blood Substitutes Sales Market by Company in 2022 (Kiloton)
Figure 33. Global Synthetic Blood Substitutes Sales Market Share by Company in 2022
Figure 34. Synthetic Blood Substitutes Revenue Market by Company in 2022 ($ Million)
Figure 35. Global Synthetic Blood Substitutes Revenue Market Share by Company in 2022
Figure 36. Global Synthetic Blood Substitutes Sales Market Share by Geographic Region (2018-2023)
Figure 37. Global Synthetic Blood Substitutes Revenue Market Share by Geographic Region in 2022
Figure 38. Americas Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 39. Americas Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 40. APAC Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 41. APAC Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 42. Europe Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 43. Europe Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 44. Middle East & Africa Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 45. Middle East & Africa Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 46. Americas Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 47. Americas Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 48. Americas Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 49. Americas Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 50. United States Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 51. Canada Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 52. Mexico Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 53. Brazil Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 54. APAC Synthetic Blood Substitutes Sales Market Share by Region in 2022
Figure 55. APAC Synthetic Blood Substitutes Revenue Market Share by Regions in 2022
Figure 56. APAC Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 57. APAC Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 58. China Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 59. Japan Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 60. South Korea Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 61. Southeast Asia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 62. India Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 63. Australia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 64. China Taiwan Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 65. Europe Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 66. Europe Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 67. Europe Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 68. Europe Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 69. Germany Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 70. France Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 71. UK Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 72. Italy Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 73. Russia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 74. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 75. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 76. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 77. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 78. Egypt Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 79. South Africa Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 80. Israel Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 81. Turkey Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 82. GCC Country Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 83. Manufacturing Cost Structure Analysis of Synthetic Blood Substitutes in 2022
Figure 84. Manufacturing Process Analysis of Synthetic Blood Substitutes
Figure 85. Industry Chain Structure of Synthetic Blood Substitutes
Figure 86. Channels of Distribution
Figure 87. Global Synthetic Blood Substitutes Sales Market Forecast by Region (2024-2029)
Figure 88. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Region (2024-2029)
Figure 89. Global Synthetic Blood Substitutes Sales Market Share Forecast by Type (2024-2029)
Figure 90. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Type (2024-2029)
Figure 91. Global Synthetic Blood Substitutes Sales Market Share Forecast by Application (2024-2029)
Figure 92. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Synthetic Blood Substitutes
Figure 2. Synthetic Blood Substitutes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Synthetic Blood Substitutes Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Synthetic Blood Substitutes Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Synthetic Blood Substitutes Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemoglobin-Based Oxygen Carriers (HBOCs)
Figure 10. Product Picture of Perfluorocarbon (PFCs)
Figure 11. Product Picture of Others
Figure 12. Global Synthetic Blood Substitutes Sales Market Share by Type in 2022
Figure 13. Global Synthetic Blood Substitutes Revenue Market Share by Type (2018-2023)
Figure 14. Synthetic Blood Substitutes Consumed in Cardiovascular Diseases
Figure 15. Global Synthetic Blood Substitutes Market: Cardiovascular Diseases (2018-2023) & (Kiloton)
Figure 16. Synthetic Blood Substitutes Consumed in Anemia
Figure 17. Global Synthetic Blood Substitutes Market: Anemia (2018-2023) & (Kiloton)
Figure 18. Synthetic Blood Substitutes Consumed in Malignant Neoplasm
Figure 19. Global Synthetic Blood Substitutes Market: Malignant Neoplasm (2018-2023) & (Kiloton)
Figure 20. Synthetic Blood Substitutes Consumed in Injuries and Trauma
Figure 21. Global Synthetic Blood Substitutes Market: Injuries and Trauma (2018-2023) & (Kiloton)
Figure 22. Synthetic Blood Substitutes Consumed in Neonatal Conditions
Figure 23. Global Synthetic Blood Substitutes Market: Neonatal Conditions (2018-2023) & (Kiloton)
Figure 24. Synthetic Blood Substitutes Consumed in Maternal Conditions
Figure 25. Global Synthetic Blood Substitutes Market: Maternal Conditions (2018-2023) & (Kiloton)
Figure 26. Synthetic Blood Substitutes Consumed in Organ Transplant
Figure 27. Global Synthetic Blood Substitutes Market: Organ Transplant (2018-2023) & (Kiloton)
Figure 28. Synthetic Blood Substitutes Consumed in Others
Figure 29. Global Synthetic Blood Substitutes Market: Others (2018-2023) & (Kiloton)
Figure 30. Global Synthetic Blood Substitutes Sales Market Share by Application (2022)
Figure 31. Global Synthetic Blood Substitutes Revenue Market Share by Application in 2022
Figure 32. Synthetic Blood Substitutes Sales Market by Company in 2022 (Kiloton)
Figure 33. Global Synthetic Blood Substitutes Sales Market Share by Company in 2022
Figure 34. Synthetic Blood Substitutes Revenue Market by Company in 2022 ($ Million)
Figure 35. Global Synthetic Blood Substitutes Revenue Market Share by Company in 2022
Figure 36. Global Synthetic Blood Substitutes Sales Market Share by Geographic Region (2018-2023)
Figure 37. Global Synthetic Blood Substitutes Revenue Market Share by Geographic Region in 2022
Figure 38. Americas Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 39. Americas Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 40. APAC Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 41. APAC Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 42. Europe Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 43. Europe Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 44. Middle East & Africa Synthetic Blood Substitutes Sales 2018-2023 (Kiloton)
Figure 45. Middle East & Africa Synthetic Blood Substitutes Revenue 2018-2023 ($ Millions)
Figure 46. Americas Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 47. Americas Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 48. Americas Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 49. Americas Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 50. United States Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 51. Canada Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 52. Mexico Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 53. Brazil Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 54. APAC Synthetic Blood Substitutes Sales Market Share by Region in 2022
Figure 55. APAC Synthetic Blood Substitutes Revenue Market Share by Regions in 2022
Figure 56. APAC Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 57. APAC Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 58. China Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 59. Japan Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 60. South Korea Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 61. Southeast Asia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 62. India Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 63. Australia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 64. China Taiwan Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 65. Europe Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 66. Europe Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 67. Europe Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 68. Europe Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 69. Germany Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 70. France Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 71. UK Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 72. Italy Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 73. Russia Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 74. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Country in 2022
Figure 75. Middle East & Africa Synthetic Blood Substitutes Revenue Market Share by Country in 2022
Figure 76. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Type (2018-2023)
Figure 77. Middle East & Africa Synthetic Blood Substitutes Sales Market Share by Application (2018-2023)
Figure 78. Egypt Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 79. South Africa Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 80. Israel Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 81. Turkey Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 82. GCC Country Synthetic Blood Substitutes Revenue Growth 2018-2023 ($ Millions)
Figure 83. Manufacturing Cost Structure Analysis of Synthetic Blood Substitutes in 2022
Figure 84. Manufacturing Process Analysis of Synthetic Blood Substitutes
Figure 85. Industry Chain Structure of Synthetic Blood Substitutes
Figure 86. Channels of Distribution
Figure 87. Global Synthetic Blood Substitutes Sales Market Forecast by Region (2024-2029)
Figure 88. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Region (2024-2029)
Figure 89. Global Synthetic Blood Substitutes Sales Market Share Forecast by Type (2024-2029)
Figure 90. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Type (2024-2029)
Figure 91. Global Synthetic Blood Substitutes Sales Market Share Forecast by Application (2024-2029)
Figure 92. Global Synthetic Blood Substitutes Revenue Market Share Forecast by Application (2024-2029)
